Vimarsana
Biggest News Aggregation in the World

Frederic Dargelas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Frederic Dargelas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Frederic Dargelas Today - Breaking & Trending Today

Iveric Bio and DelSiTech: DelSiTech and Iveric Bio Enter Exclusive Agreement for Development of Sustained Release Zimura - Vimarsana News

Iveric Bio and DelSiTech: DelSiTech and Iveric Bio Enter Exclusive Agreement for Development of Sustained Release Zimura

Published: July 6, 2022

PARSIPPANY, N.J. and TURKU, Finland, July 6, 2022 /PRNewswire/ -- IVERIC bio, Inc. (Nasdaq: ISEE) and DelSiTech Ltd, announced today an exclusive global license agreement providing Iveric Bio

Source: finanznachrichten.de
Related Topics:
Frederic DargelasLasse LeinoPravinu DugelIveric BioGlennp SblendorioAlliance ManagementDelsitech LtdEuropean Medicines AgencyDrug AdministrationHead Of Business DevelopmentChief Executive OfficerBusiness DevelopmentSitech Ltd
DelSiTech and Iveric Bio Enter Exclusive Agreement for Development of Sustained Release Zimura® - Vimarsana News

DelSiTech and Iveric Bio Enter Exclusive Agreement for Development of Sustained Release Zimura®

Published: July 6, 2022

/PRNewswire/ -- IVERIC bio, Inc. (Nasdaq: ISEE) and DelSiTech Ltd, announced today an exclusive global license agreement providing Iveric Bio with the right to...

Source: prnewswire.com
Related Topics:
Frederic DargelasLasse LeinoPravinu DugelIveric BioGlennp SblendorioAlliance ManagementDelsitech LtdEuropean Medicines AgencyDrug AdministrationHead Of Business DevelopmentChief Executive OfficerBusiness DevelopmentSitech LtdIveric Bio And DelsitechHealth Care Amp Hospitals Pharmaceuticals Medical Pharmaceuticals Biotechnology
IVERIC bio, Inc.: Iveric Bio and DelSiTech Enter Exclusive Agreement for Development of Sustained Release Zimura - Vimarsana News

IVERIC bio, Inc.: Iveric Bio and DelSiTech Enter Exclusive Agreement for Development of Sustained Release Zimura

Published: July 5, 2022

IVERIC bio, Inc. (Nasdaq: ISEE) and DelSiTech Ltd, announced today an exclusive global license agreement providing Iveric Bio with the right to develop and commercialize new formulations of Zimura

Source: finanznachrichten.de
Related Topics:
Frederic DargelasLasse LeinoPravinu DugelKathy GalanteIveric BioJeannie NeufeldGlennp SblendorioDelsitech LtdAlliance Management For DelsitechDrug AdministrationWhile The CompanyPublic Relations CommunicationsExchange CommissionEuropean Medicines AgencyHead Of Business DevelopmentChief Executive OfficerBusiness DevelopmentAlliance ManagementSitech LtdPrivate Securities Litigation Reform ActVice PresidentInvestor Relations